View in EDS HTML Full Text PDF Full Text

RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway.

Saved in:

Bibliographic Details
Title:	RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway.
Authors:	Xie, Yang^1,2 (AUTHOR), Li, Qi^1,2,3 (AUTHOR), Ma, Yecheng^1,2 (AUTHOR), Yang, Yongchang^1,2 (AUTHOR), Jin, Xingyu^1,2 (AUTHOR), Yi, Tailong¹ (AUTHOR), Ge, Xianglian¹ (AUTHOR), Xu, Xing¹ (AUTHOR), Yang, Xuejun⁴ (AUTHOR), Huang, Qiang⁵ (AUTHOR), Lu, Yalin⁶ (AUTHOR), Li, Peng⁶ (AUTHOR), Li, Wenliang⁶ (AUTHOR), Wang, Xiaoguang⁶ (AUTHOR), Piao, Yingzhe⁶ (AUTHOR) 13602132633@163.com, Jin, Xun¹ (AUTHOR) jinx2354@163.com
Source:	Scientific Reports. 11/28/2025, Vol. 15 Issue 1, p1-15. 15p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20452322
DOI:	10.1038/s41598-025-30291-z